Tesla Inc. CEO Elon Musk expressed his concerns over the COVID-19 vaccine dosage, citing his own adverse experience.
Musk took to X on Sunday and claimed that his second vaccine shot was so severe that it almost led him to hospitalization. “My second vaccine shot almost sent me to the hospital. Felt like I was dying.” He compared his vaccine experience with his encounter with the original coronavirus, which he described as like any other cold or flu. “Bad, but not terrible,” said Musk.
Musk’s post was in response to a post by Peter Sweden, who highlighted the claims of a Pfizer Inc. insider and former head of toxicology, estimating that between 20,000 and 60,000 people in Germany have died from the COVID-19 vaccine.
“The vaccine dosage was obviously too high and done too many times,” wrote Musk.
The vaccine dosage was obviously too high and done too many times.
I had the original Wuhan virus before there was any vaccine and it was much like any other cold/flu. Bad, but not terrible.
But my second vaccine shot almost sent me to the hospital. Felt like I was dying. https://t.co/rFuUpzBkKH
— Elon Musk (@elonmusk) April 12, 2026
Don’t Miss:
Pfizer did not immediately respond to Benzinga’s request for comments
Vaccine Debate Intensifies
Musk’s comments come amidst a backdrop of ongoing debates and concerns surrounding COVID-19 vaccines. Pfizer Inc. and BioNTech SE recently paused their COVID-19 vaccine trial due to falling enrollment.
A report in September by the Washington Post also revealed that the Trump administration’s health officials were looking to link vaccines to 25 child deaths using unverified VAERS submissions, raising alarm among career scientists who stress the vaccines are well-studied.
The claim was expected to be presented to the CDC’s Advisory Committee on Immunization Practices, which was considering stricter recommendations that could affect insurance coverage and access.
See Also: Avoid the #1 Investing Mistake: How Your ‘Safe’ Holdings Could Be Costing You Big Time
In December, the FDA was reportedly considering a highest-level boxed warning for COVID-19 vaccines, a move criticized by experts as unsupported by evidence. A boxed warning is the most prominent label on a medication, used to highlight its most serious risks.
Meanwhile, a report last week suggested that the acting CDC director delayed a study showing COVID-19 vaccines reduced ER visits by 50% and hospitalizations by 55% among healthy adults, citing methodology concerns despite the approach being widely used.
Photo courtesy: Frederic Legrand – COMEO from Shutterstock
Read Next:
UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets.
Get the latest stock analysis from Benzinga:
